Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Global CEO confidence fell in the third quarter to its lowest level in two years, but chief executives remain confident about growth prospects in the U.S., according to the Conference Board. The overall measure of CEO confidence decreased to a level of 55 from 63 in the second quarter. A reading of more than 50
Hiring top executives who can both effectively manage and lead an organization is a major challenge. When a company makes vital senior-level appointments, the risks are high. For top roles, the base salary is typically more than $150,000. When searching, organizations will be looking for the most suitable candidate who checks off all the boxes, including
The Conference Board’s latest measure of CEO confidence, which had increased in the first quarter of 2018, declined slightly in the second quarter. The measure now reads 63, down from 65 in the first quarter of 2018. A reading of more than 50 points reflects more positive than negative responses. “CEO Confidence declined slightly in the
Executive search firm Slone Partners has placed Bob Beechey as the new CFO of Vermillion Inc., a bio-analytical solutions company focused on gynecologic disease. “Bob is a brilliant financial mind whose experience managing the business and commercial aspects of healthcare companies will prove invaluable to Vermillion,” said Tara Kochis-Stach, president of Slone Partners. Mr. Beechey has served
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025